Clinical Trial Update: Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin [Phase 3]

View source ↗

Summary

A Phase 3 safety trial of levocetirizine dihydrochloride oral solution in children aged 1 to under 6 with allergic rhinitis or chronic urticaria has completed, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Urticaria

Drugs mentioned

• Levocetirizine dihydrochloride oral solution (levocetirizine dihydrochloride)

Snippet

Sponsor: UCB Pharma | Conditions: Allergic Rhinitis, Chronic Urticaria | Phase 3 | Status: COMPLETED | Results posted: 2009-09-04